Navigation Links
Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
Date:5/1/2008

Company to Provide Financial Guidance for Fiscal 2008 through 2010

PITTSBURGH, May 1 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today that it will host a conference call and live webcast on Thursday, May 8, 2008, at 5 p.m. ET to provide a review of the first quarter ended March 31, 2008. The company also will provide updated financial guidance for fiscal 2008 through fiscal 2010 and an operational and integration update on Merck Generics, which the company acquired on Oct. 2, 2007. The company will release its financial results after the market closes May 8.

The dial-in number to access the May 8 call is 877-719-9810 or 719-325-4793 for international callers. A replay, available for approximately seven days, will be available at 888-203-1112 or 719-457-0820 for international callers with access pass code 4576196.

To access a live webcast of the May 8 call, please log on to Mylan's Web site (http://www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on http://www.mylan.com for approximately seven days.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest-and highest quality-product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information about Mylan, visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Declares Quarterly Preferred Stock Dividend
2. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
3. Mylan Announces Final FDA Approval for Trandolapril Tablets
4. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
5. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
6. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
7. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
8. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
9. Mylan Restores Availability of Generic Levothyroxine in Florida
10. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
11. Mylan Declares Quarterly Preferred Stock Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 20, 2017 , ... Pixel ... created specifically for use in Final Cut Pro X. The business-oriented elements and ... Pixel Film Studios’ ProParagraph Corporate will deliver a professional and distinguished look to ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 years United ... range of knives and swords, from functional to fantasy. United Cutlery has always been ... modern designs that defy tradition. , Offering a range of weapons and tools built ...
(Date:5/19/2017)... Charlotte, NC (PRWEB) , ... May 19, 2017 ... ... of the Charlotte health community, Queens University of Charlotte recently began recruitment efforts ... The program’s curriculum arms students with the skills, knowledge and expertise to approach ...
(Date:5/19/2017)... ... 19, 2017 , ... The Hill Agencies, a family managed firm that offers ... Central Valley, is announcing a joint charity initiative with the Boys and Girls Club ... camp event. , The Boys and Girls Club of Kern County gives young people ...
(Date:5/19/2017)... ... 2017 , ... As a groundbreaking surgeon on the frontline of prostate cancer ... Early detection of the disease, he says, can make a world of difference. ... stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and its ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
(Date:5/4/2017)... LAWRENCE, Mass. and SAN DIEGO ... of Obstetricians and Gynecologists (ACOG) 2017 Annual Clinical and ... of single-use, self-contained, illuminating medical devices, today announced the ... size of its OfficeSPEC and ER-SPEC ... large, the addition of extra-small and extra-large sizes makes ...
(Date:5/4/2017)... 4, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... "Company"), today announced that the Company,s first quarter 2017 ... Thursday, May 11, 2017, and that the Company will ... p.m. PT that afternoon. Management will provide an overview ...
Breaking Medicine Technology: